• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    Elite Pharmaceuticals, Inc. (ELTP)

    -Other OTC
    0.27 Up 0.01(5.16%) Jan 30, 3:57PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Elite Pharmaceuticals, Inc.
    165 Ludlow Avenue
    Northvale, NJ 07647
    United States - Map
    Phone: 201-750-2646
    Fax: 201-750-2755
    Website: http://www.elitepharma.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Other
    Full Time Employees:38

    Business Summary 

    Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, principally engaged in the research, development, and licensing of proprietary controlled-release drug delivery systems and products. The company develops orally administered controlled-release products for various therapeutic areas, including pain, allergy, and infection. It owns, licenses, sells, and contract manufactures Phentermine tablets and capsules, Lodrane D Immediate Release capsules, Methadone tablets, Hydromorphone Hydrochloride tablets, Phendimetrazine tartrate tablets, and Naltrexone HCl tablets. The company also has a pipeline of other generic drug candidates under development; and is developing abuse resistant opioid products and once-daily opioid products. In addition, it is engaged in contract research and development on behalf of other pharmaceutical companies. The company has strategic alliance agreements with Epic Pharma, LLC and Epic Investments, LLC. Elite Pharmaceuticals, Inc. was founded in 1984 and is headquartered in Northvale, New Jersey.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Elite Pharmaceuticals, Inc.

    Key Executives 
    Mr. Nasrat Hakim , 54
    Chief Exec. Officer, Pres and Director
    Mr. Carter J. Ward B.S., CPA, 51
    Chief Financial Officer, Chief Accounting Officer, Treasurer and Sec.
    Mr. Ashok G. Nigalaye Ph.D., 63
    Chief Scientific Officer, Director and Member of Compensation Committee
    Mr. Christopher C. Dick , 60
    Mr. Doug Plassche ,
    Exec. VP of Operations
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders